Diabetes SpectrumPub Date : 2025-02-14eCollection Date: 2025-01-01DOI: 10.2337/dsi24-0015
Shubham Agarwal, Julia K Mader, Giuliana Arevalo, Sreekant Avula, Efren Chavez, Lance A Sloan, Rodolfo J Galindo
{"title":"Diabetes and Glucose Management in People on Hemodialysis.","authors":"Shubham Agarwal, Julia K Mader, Giuliana Arevalo, Sreekant Avula, Efren Chavez, Lance A Sloan, Rodolfo J Galindo","doi":"10.2337/dsi24-0015","DOIUrl":"10.2337/dsi24-0015","url":null,"abstract":"<p><p>Diabetes is a major cause of end-stage kidney disease (ESKD). Glycemic management is challenging in this population, and A1C, commonly used for monitoring glycemic control, is unreliable. Continuous glucose monitoring indices can be used for glycemic monitoring in people with ESKD. Dipeptidyl peptidase 4 inhibitors, incretin mimetic agents (glucagon-like peptide 1 and glucose-dependent insulinotropic peptide receptor agonists), and insulin using an automated insulin delivery system are preferred to manage diabetes in people with ESKD on hemodialysis.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"7-18"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825408/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2025-02-14eCollection Date: 2025-01-01DOI: 10.2337/dsi24-0014
Elizabeth A Beverly, Jeffrey S Gonzalez
{"title":"The Interconnected Complexity of Diabetes and Depression.","authors":"Elizabeth A Beverly, Jeffrey S Gonzalez","doi":"10.2337/dsi24-0014","DOIUrl":"10.2337/dsi24-0014","url":null,"abstract":"<p><p>Diabetes and depression have a bidirectional relationship, with negative impacts on glycemia, self-care, long-term complications, quality of life, and mortality. This review highlights key aspects of the interconnected and complex relationship between diabetes and depression, including how it affects health outcomes, depression duration and recurrence, age-specific manifestations, and recommendations for screening and nonpharmacological treatment.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"23-31"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825406/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433882","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2025-02-14eCollection Date: 2025-01-01DOI: 10.2337/dsi24-0016
T Y Alvin Liu, Risa M Wolf
{"title":"Autonomous Artificial Intelligence for Diabetic Eye Disease Testing Improves Access and Equity in the Pediatric and Adult Populations: The Johns Hopkins Medicine Experience.","authors":"T Y Alvin Liu, Risa M Wolf","doi":"10.2337/dsi24-0016","DOIUrl":"10.2337/dsi24-0016","url":null,"abstract":"<p><p>This article discusses the implementation and impact of autonomous artificial intelligence (AI) systems for diabetic eye disease testing at the Johns Hopkins Medicine health system, highlighting improvements in screening rates, access to care, and health equity for underserved populations. The AI technology has been effective in both adult and pediatric populations and has reduced disparities and increased follow-up with eye care professionals. While considering the challenges and successes of this approach, this article also highlights the potential long-term impact of AI systems in improving visual health outcomes for people with diabetes in diverse health care settings.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"19-22"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825398/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2025-02-14eCollection Date: 2025-01-01DOI: 10.2337/ds25-en01
{"title":"A Sincere Thank You to the Reviewers of <i>Diabetes Spectrum</i>.","authors":"","doi":"10.2337/ds25-en01","DOIUrl":"10.2337/ds25-en01","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"32"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825393/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434246","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2025-02-14eCollection Date: 2025-01-01DOI: 10.2337/dsi24-0018
Lance A Sloan
{"title":"Diabetes in Special Populations.","authors":"Lance A Sloan","doi":"10.2337/dsi24-0018","DOIUrl":"10.2337/dsi24-0018","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2025-02-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143434252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2025-01-06eCollection Date: 2025-01-01DOI: 10.2337/ds24-0079
Joshua J Neumiller
{"title":"Meeting People Where They Are: Improving Diabetes Care and Outcomes Through Education and Collaboration.","authors":"Joshua J Neumiller","doi":"10.2337/ds24-0079","DOIUrl":"10.2337/ds24-0079","url":null,"abstract":"<p><p>This article is adapted from the address Dr. Neumiller delivered as the recipient of the American Diabetes Association's Outstanding Educator in Diabetes Award for 2024. He delivered the address in June 2024 during the Association's 84th Scientific Sessions.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"38 1","pages":"115-120"},"PeriodicalIF":0.0,"publicationDate":"2025-01-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11825400/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143433936","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2024-11-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0004
W Timothy Garvey
{"title":"Future Medications for Obesity and Clinical Implications.","authors":"W Timothy Garvey","doi":"10.2337/dsi24-0004","DOIUrl":"10.2337/dsi24-0004","url":null,"abstract":"<p><p>Semaglutide and tirzepatide have recently been approved for obesity and found to achieve ≥15% weight loss in clinical trials. These drugs have been referred to as second-generation medications because the unprecedented degree of weight loss they afford is sufficient to treat or prevent a broad array of obesity complications and related diseases. Many other medications are in development based on the actions of nutrient-regulated hormones (NRHs), including mono-, dual-, and triple-receptor agonists/antagonists for glucagon-like peptide 1, glucose-dependent insulinotropic polypeptide, amylin, peptide tyrosine-tyrosine, and glucagon. Clinical trial evidence is accumulating that these medications ameliorate multiple biomechanical, metabolic, and vascular complications of obesity. These tools enable a comprehensive complications-centric approach to care within the contextual framework of the diagnostic term adiposity-based chronic disease (ABCD). The potential to reduce patient suffering and the huge social burden of ABCD is profound. The current era of drug development based on NRHs could represent a landmark in the history of medicine provided that societies ensure access to these medications for the patients who need them.</p>","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 4","pages":"325-334"},"PeriodicalIF":0.0,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Diabetes SpectrumPub Date : 2024-11-15eCollection Date: 2024-01-01DOI: 10.2337/dsi24-0006
W Timothy Garvey
{"title":"A Focus on the Pharmacotherapy of Obesity.","authors":"W Timothy Garvey","doi":"10.2337/dsi24-0006","DOIUrl":"10.2337/dsi24-0006","url":null,"abstract":"","PeriodicalId":39737,"journal":{"name":"Diabetes Spectrum","volume":"37 4","pages":"275-279"},"PeriodicalIF":0.0,"publicationDate":"2024-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11623036/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142802668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}